Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 pediatric trial evaluating pharmacokinetics, safety, and efficacy of Glecaprevir/Pibrentasvir in children with genotypes 1–6 chronic HCV; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Glecaprevir/pibrentasvir (glecaprevir/pibrentasvir)

Snippet

Sponsor: AbbVie | Conditions: Hepatitis C Virus (HCV) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-07-13